Plasmalogens are a type of lipid that contain an alkenyl ether linked to glycerol in contrast to the ester linkages in phosphatidyl ethanolamine and phosphatidyl choline. The alkenyl ethers react readily in aqueous acids to form aldehydes. Rapport and Lerner have shown that nearly all the aldehydes detected with acidic reagents in lipid preparations from mammalian tissues arise from plasmalogens (1). Plasmalogens constitute up to 70 per cent of the cephalin fraction of brain lipids (2) and 55 per cent of the lecithin fraction of heart lipids (3). These relatively large amounts of plasmalogen suggest that degenerative diseases of the myocardium or central nervous system might elevate the plasmalogen level in the serum and be of diagnostic or prognostic value. In human brain the plasmalogen content is approximately 25 /Amoles per g (wet weight) of white matter (1), and in normal human infants the serum plasmalogen level is 0.03 + 0.02 umole per ml. In a 10-kg infant, with a blood volume of 800 ml and a hematocrit of 36 per cent (4), the total plasmalogen in the serum would be approximately 14 + 10 umoles. Therefore, the destruction of 1 g of white matter * This project was supported in part by Grant G-7647 from the National Science Foundation. A preliminary survey of hospital patients with encephalitis, Niemann-Pick's disease, or myocardial infarction showed no consistent elevation of serum plasmalogen. This finding had been reported previously for a variety of diseases that did not, however, involve destruction of tissues rich in plasmalogen (5). The lack of correlation between pathological states and serum levels suggested either that plasmalogen is not released immediately upon tissue destruction or that rapid removal of plasmalogen from the blood is preventing its accumulation in the serum to any appreciable extent. In order to investigate the disappearance of plasmalogen from the circulation, an emulsion of phospholipids containing plasmalogen was injected into rabbits and shown to be rapidly removed from the circulation.
Plasmalogens are a type of lipid that contain an alkenyl ether linked to glycerol in contrast to the ester linkages in phosphatidyl ethanolamine and phosphatidyl choline. The alkenyl ethers react readily in aqueous acids to form aldehydes. Rapport and Lerner have shown that nearly all the aldehydes detected with acidic reagents in lipid preparations from mammalian tissues arise from plasmalogens (1) . Plasmalogens constitute up to 70 per cent of the cephalin fraction of brain lipids (2) and 55 per cent of the lecithin fraction of heart lipids (3). These relatively large amounts of plasmalogen suggest that degenerative diseases of the myocardium or central nervous system might elevate the plasmalogen level in the serum and be of diagnostic or prognostic value. In human brain the plasmalogen content is approximately 25 /Amoles per g (wet weight) of white matter (1) , and in normal human infants the serum plasmalogen level is 0.03 + 0.02 umole per ml. In a 10-kg infant, with a blood volume of 800 ml and a hematocrit of 36 per cent (4) , the total plasmalogen in the serum would be approximately 14 + 10 umoles. Therefore, the destruction of 1 g of white matter could liberate sufficient plasmalogen to elevate the serum level by 100 per cent or more.
A preliminary survey of hospital patients with encephalitis, Niemann-Pick's disease, or myocardial infarction showed no consistent elevation of serum plasmalogen. This finding had been reported previously for a variety of diseases that did not, however, involve destruction of tissues rich in plasmalogen (5) . The lack of correlation between pathological states and serum levels suggested either that plasmalogen is not released immediately upon tissue destruction or that rapid removal of plasmalogen from the blood is preventing its accumulation in the serum to any appreciable extent. In order to investigate the disappearance of plasmalogen from the circulation, an emulsion of phospholipids containing plasmalogen was injected into rabbits and shown to be rapidly removed from the circulation.
METHODS AND MATERIALS
Plasmalogen preparation. Lipids were extracted from 2 kg of fresh beef heart by successive homogenization with 2 L methanol, and 2 and then 1.5 L 50 per cent methanol in chloroform.' Chloroform was added to these extracts to make a final solution of 33 per cent methanol in chloroform. The extract was washed with one-fifth volume of water and the water layer removed. The extract was evaporated to dryness and redissolved in 30 ml of 10 per cent methanol in chloroform. Acetone, 800 ml, was added and the solution refrigerated overnight. The acetone-insoluble precipitate was separated by centrifugation, dried, dissolved in ether, and added to a 400-g silicic acid column (Baker, 100-200 mesh) moistened with ether. After removal of the neutral lipids with 1. Analysis of material. Analyses were performed on the cephalin fraction (Table I) for amino nitrogen by the method of Lea and Rhodes (6); for aldehyde, with fuchsin sulfurous acid (7); for alkenyl ether, by iodometric titration (8) ; for esters, by hydroxamate formation (9) ; and for phosphorus, with ammonium molybdate (10) . This fraction was used to prepare the plasmalogen emulsion.
Preparation of emulsion. The cephalin emulsion was prepared immediately before injection by evaporation of 4 ml of the cephalin fraction in 33 per cent methanol in chloroform to dryness in vacito at 40°C. The material was then dissolved in 1 ml of diethyl ether and to it was added 8 ml of a 0.1 N phosphate buffer at AH 7.4 maintained at 370 C. The ether was blown off with nitrogen. Then 0.1 ml of a 10 per cent solution of Tween 20 in phosphate buffer was added. The material was vigorously shaken and sonicated for 30 minutes in a 250-watt Raytheon Sonicator. The emulsion did not change in appearance when kept at 5 to 100 C until 3 to 4 days' time, when a precipitate began to form. The particle size of the emulsified lipids was not determined. Injection procedure. Adult male rabbits were maintained on Rockland Rabbit Food and water at will. They were weighed immediately before each experiment and anesthetized with sodium pentobarbital in distilled water given intraperitoneally, 38 mg per kg body weight. The external jugular or femoral vein was exposed, opened, and a no. 19 or 22 polyethylene catheter was inserted to a distance of 5 to 8 cm. A thfree-way stop-cock was placed between the catheter and syringe to prevent air entering the venous system. Blood samples of 6 ml were taken and that volume replaced with 0.9 per cent NaCl injected through the catheter. Injections of 4 ml of the cephalin emulsion containing 20 /imoles of plasmalogen were made through the catheter. Before injection, 4 ml of blood was drawn into the syringe and mixed with the 4 ml of emulsion. After inj ection, the catheter was flushed with 0.9 per cent NaCl solution. In some cases, the abdominal cavity was opened and at various times a portion of liver, of about 10 gm, was removed distal to a Blood analyses. The blood samples were allowed to coagulate, and the serum was separated by centrifugation and frozen until the time of analysis. Lipids were extracted from 0.5 ml of serum by two treatments with 7 ml of 50 per cent methanol in chloroform. The lipid extract was washed with one-fifth volume of water to remove inorganic phosphates and other water-soluble contaminants. The aldehyde content was then determined by the colorimetric method described above.
Whole blood was collected wvith sodium citrate as an anticoagulant. The plasma weas removed after centrifugation and the erythrocytes washed once with 0.9 per cent NaCl. The cells were then hemolyzed by freezing and thawing. An extract was made from the hemolysate as described above for serum.
Liver and lung analysis. Tissue samples were frozen immediately after removal and stored until the time of analysis. Liver and lung samples were weighed after thawing. The lipids were extracted from 5-to 10-g samples by homogenizing the tissue successively with 20 ml of methanol, 20 ml of 50 per cent methanol in chloroform, and 30 ml of 33 per cent methanol in chloroform. Chloroform was added to the combined extract to make a final solution of 33 per cent methanol in chloroform. The extract was then washed with one-fifth volume of water, and the water layer removed. The organic phase was diluted to 50 ml in a volumetric flask and samples taken for aldelhyde analysis.
Tissue inctbatioits. Rabbit liver was homogenized in 3 volumes of 0.25 M sucrose containing 0.001 M Versene-9. The total homogenate was incubated with either the cephalin emulsion or a'-(1-alkeniyl) -glycerylphosphoryl ethanolaminiile (alkeniyl-GPE) 2 prepared by a modificationl of the method of Hartree and Mann (11) . Alkenyl-GPE, 0.5 to 1.0 Mmole, was dissolved in 1 ml of a 0.1 M phosphate buffer at pH 7.1. The tissue homogenate, 0.1 ml, was added and the mixture incubated at 370 C. Samples of 0.1 ml each were withdrawn from the incubation mixture at the specified intervals. The alkenyl ether content was determined with fuchsin sulfurous acid after destruction of the liberated aldehyde by alkaline peroxide (12) .
RESULTS
In the rabbits used, the average serum plasmalogen level was 0.009 jumole per ml, ranging from 0.001 to 0.031 /Amole per ml. With an average weight of 4 kg and plasma volume of 38 ml per kg ranging from 27 to 48 ml per kg (13), the total plasma plasmalogen varied between 0. 15 and 4.71 Mmoles. Therefore the injection of 20 umoles of plasaialogen far exceeded the endogenous plasma -Abbreviations used are: alkenyl-GPE, a'-(1-alkenyl) -glycerylphosphoryl ethanolamine; alkenyl-GPC, a'-(lalkenyl) -glycerylphosphoryl choline. Ordinate represents calculated percentage of injected aldehyde recovered from the blood stream. Plasma volume calculated at 38 ml per kg (13 plasmalogen. Figure 1 /Amoles of plasmalogen, any significant trapping in the pulmonary bed would have been easily demonstrated.
The liver is known to be the principal site of formation of the plasma phospholipids (15) . It is also active in removing phospholipids from the bloodstream (16). Because the liver exerts these controls on phospholipid metabolism, analyses of liver samples for aldehyde were performed at various intervals before and after plasmalogen injection. Table II Figure 2A shows a progressive increase in the aldehyde content of the liver which is proportional to the decrease in circulating aldehyde. This experiment demonstrates that the liver is capable of removing injected plasmalogen from the blood stream. In a second animal, however, only 17 per cent of the injected plasmalogen appeared in the liver at the end of 3 hours. This could mean that the liver (13) . plasmalogen is present in the liver. This suggests that the plasmalogen is being metabolized by the hepatic tissue at a rate equal to or greater than its removal from the blood stream. Support for this possibility comes from the demonstration of an enzyme in rat liver microsomes that will hydrolyze the alkenyl ether linkage of alkenyl-GPC (7). Figure 3 shows the results of incubating rabbit tissue with the cephalin emulsion and alkenyl-GPE. The emulsion of cephalin is not (legraded in 1 hour by rabbit liver homogenates, whereas 75 per cent of the alkenyl-GPE is hy-(lrolyzed in that time. (17) and it accumti-plasmnalogen deprivation lowers them (18) . Seby the re-rum plasmalogen levels are decreased with growth experiment hormone (19) , and increased with adrenocorticoilogen from trophic hormone and adrenalin (5 (22) . Neither the amount nor the physical state of the plasmalogen injected is presumed to be physiological. Even under these conditions, however, this work demonstrates that plasmalogen is not physiologically inert. In the blood and tissue analyses, plasmalogen level was determined by the fuchsin method. These levels may represent the sum of the injected plasmalogen and any fatty aldehyde released by the hydrolysis of plasmalogen. The aldehyde probably does not remain in either the plasma or the liver, since Feulgen, Imhduser, and Westhues have shown that injected aldehyde cannot be detected in the blood stream (14) . Also, the free aldehyde released from alkenyl-GPC in liver homogenate incubations disappears rapidly (7) .
Our data show that the lungs and the erythrocytes do not accumulate injected plasmalogen. Feulgen and associates demonstrated in an in vitro system that defibrinogenated blood will not destroy added plasmalogen (14) . Leupold and Buttner suggest that free fatty aldehydes, but not plasmalogen, will be rapidly oxidized in the lungs. These results suggest that neither tissue is involved in removing plasmalogen from the circulation.
Plasmalogen accumulated in the liver after injection. The percentage recovered there varied, however, and in one case began to decline after an initial elevation, suggesting that the plasmalogen was being metabolized. The whole homogenate of rabbit liver can hydrolyze alkenyl-GPE but apparently not the cephalin emulsion. The results are similar to those previously described for rat tissue (7) , and show that the alkenyl ether cannot be hydrolyzed until the adjacent acyl group is removed. Presumably the action of a phospholipase in intact liver tissue could convert cephalin plasmalogen to alkenyl-GPE which would then be further hydrolyzed. This necessity for initial cleavage of fatty acid from the phospholipid accentuates the importance of phospholipases in plasmalogen breakdown. Phospholipase activity is present in liver tissue, but its relative activity is low in homogenates. In the liver incubations, as in the injections, the emulsion contained a ratio of diacyl-GPE to alkenyl-acyl-GPE of approximately 4: 1 (see Table I ). Some phospholipases hy-(Irolyze diacyl-GPC more rapidly than alkenylacyl-GPC (24) . Perhaps the failure to demonstrate hydrolysis of the plastnalogen in the emulsion is the result of competitive inhibition by diacyl-GPE for the enzyme. Also, in the intact cell phospholipases may be more active. These studies show that the liver may be involved in the metabolism of plasmalogen. 
